“licensing” Archives

in
Entry Author Date Location
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations 05/27/20 New York
Biogen, Sangamo Ink Neuro Deal for New “Gene Regulation” Therapies 02/28/20 National
Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data 02/26/20 San Diego
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020 01/21/20 San Diego
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive 01/14/20 San Diego
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal 12/23/19 Boston
Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy 12/02/19 San Diego
Disc Medicine Launches With $50M to Advance New Anemia Treatments 10/29/19 Boston
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
Novartis to Pay $150M to Ionis, Akcea for Drug to Slow Heart Disease 02/25/19 San Diego
Funds for Richard’s Rainwater, New CPRIT Executive, & More TX Tech 02/15/19 Texas
DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device 01/23/19 Texas
WI Watchlist: Amazon, JCI, Understory, Titan Spine, Eurofins 11/28/18 Wisconsin
Ahead of WARF Keynote, Gigaom’s Reese Talks Academia’s Startup Push 10/12/18 Wisconsin
Bristol-Myers Bets Nearly $2B on Nektar for an Immunotherapy Boost 02/14/18 New York
UW Remains Among Global Elite in Ranking of Innovative Universities 09/27/17 Seattle
GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech 08/23/17 Boston
Cytori Reboots Azaya Facility After Buyout, Looks for European Deal 05/04/17 Texas
Fresh Off Another Banner Year, U-M Tech Transfer Looks Ahead to 2017 01/24/17 Detroit Ann Arbor
Global Innovation Exchange Plans Menu of IP Options for Students 12/05/16 Seattle
Celgene Invests More in GNS Healthcare For Machine Learning Software 11/29/16 Boston
Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD 10/13/16 Boston
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results 09/07/16 San Diego
Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires 08/09/16 Texas
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Pfizer Invests in Wave, Inks Metabolic-Focused Drug Development Deal 05/05/16 Boston
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
Former Gates Foundation Lawyer Tapped As WARF’s New Managing Director 03/24/16 Wisconsin
Page 1 of 3 next page »